Delivery Order SPE2DB22D2206-SPE2DB25FHG67
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for ORSERDU 345 mg tablets in a 30-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $27,841.82 with an ultimate completion date of August 11, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Orserdu 345 mg tablets (30-count packages) with a ceiling value of $27,841.82. This firm fixed-price delivery order, which is scheduled for completion by October 6, 2025, carries no set-aside designation and represents a competitively awarded contract. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ORSERDU 345 mg tablets (30-count) with a ceiling value of $27,841.82 under a firm fixed-price contract type. The award was announced on September 11, 2025, with an ultimate completion date of October 2, 2025. No set-aside designation was applied to this competitively awarded delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a $13,920.91 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Orserdu 345 mg tablets in quantities of 30 units. This contract utilizes firm fixed price terms with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This delivery order represents a...
- The Defense Logistics Agency awarded a $27,841.82 firm fixed price delivery order to AmerisourceBergen Drug Corp for 4569617740 ORSERDU 345 mg tablets (30-count units) on September 28, 2025, with an ultimate completion date of October 20, 2025. This non-set-aside competitive award leverages AmerisourceBergen's indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.9 million through December 2026. The vendor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $13,920.91 to AmerisourceBergen Drug Corp for Orserdu 345 mg tablets (30-count units) on August 29, 2025, with an ultimate completion date of September 22, 2025. This firm fixed price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award valued at $41,762.73 for ORSERDU 345 mg tablets (30-count units) from the Defense Logistics Agency's Medical Supply Chain on September 8, 2025. The contract represents a firm fixed-price, non-competitive delivery order with an ultimate completion date of September 29, 2025. This award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for ORSERDU 86 mg tablets (30-count units) valued at $9,394.44 under a firm fixed-price contract type. This non-set-aside delivery order is scheduled for completion by September 11, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement within the military...
- The Defense Logistics Agency awarded a delivery order valued at $13,920.91 to AmerisourceBergen Drug Corp for ORSERDU 345 mg tablets (30-count supply) on September 24, 2025, with completion targeted for October 16, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Orserdu 345 mg tablets in quantities of 30 units. This $13,920.91 firm fixed price delivery order, which is scheduled for completion by September 10, 2025, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's significant Indefinite Delivery...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FHG67Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for ORSERDU 345 mg tablets in a 30-count package configuration. This firm fixed-price delivery order, valued at $27,841.82, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, which carries a $999,999,999.00 ceiling value and extends through December 2026. The delivery order was competitively awarded with no set-aside designation and is scheduled for completion by June 27, 2025, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor to federal medical procurement programs, particularly supporting Defense Health Agency and military healthcare systems. The SPE2DX prime vendor contract under which this delivery order falls provides global pharmaceutical support to military healthcare programs and enables AmerisourceBergen to supply a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support defense and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.8k | 6/5/25 |